XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of Stock-based Compensation Expense

The following table sets forth the Company’s stock-based compensation expense for the periods indicated (in thousands):

    

Three Months Ended September 30, 

Nine Months Ended September 30, 

2023

    

2022

2023

    

2022

Equity Classified Awards

 

  

 

  

  

 

  

Cost of production

$

25

$

208

$

37

$

599

General and administrative

 

4,239

 

3,910

 

11,480

 

10,992

Other

 

(132)

 

243

 

1,235

 

1,034

Total equity classified awards

 

4,132

 

4,361

 

12,752

 

12,625

Liability Classified Awards

 

  

 

  

 

  

 

  

General and administrative

 

 

(267)

 

 

(460)

Other

 

 

126

 

 

Total liability classified awards

 

 

(141)

 

 

(460)

Total stock-based compensation

$

4,132

$

4,220

$

12,752

$

12,165

Schedule Stock Option Award Activity Stock option activity under the Company’s stock incentive plans and changes during the nine months ended September 30, 2023, were as follows:

    

    

    

Weighted-

    

Average

Weighted-

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Term

Intrinsic

Options

    

Price (1)

    

(years)

    

Value

Options outstanding at December 31, 2022

 

5,945,321

$

4.65

9.1

 

$

Granted

 

3,178,148

$

1.69

 

  

 

$

Canceled or forfeited

 

(769,529)

$

3.79

 

  

 

$

Exercised

 

$

 

  

 

$

Options outstanding at September 30, 2023

 

8,353,940

$

3.61

 

8.7

$

Options vested and expected to vest at September 30, 2023

 

3,332,229

$

4.86

 

7.2

$

(1)The exercise price of options outstanding range from $1.59 to $876.00 as of September 30, 2023. The higher end of the range is due to the impact of several reverse stock splits during the years 2015 to 2018.
Schedule of Non-vested Restricted Stock Awards Non-vested restricted stock awards and the changes during the nine months ended September 30, 2023, were as follows:

    

    

Weighted-

Average

Number of

Grant-Date

Shares

Fair Value

Outstanding at December 31, 2022

 

5,254,457

$

3.94

Granted

 

3,897,010

$

1.47

Vested and issued

 

(2,404,742)

$

4.08

Canceled or forfeited

 

(823,428)

$

3.44

Non-vested at September 30, 2023

 

5,923,297

$